DJ Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ slipped 1.74% to $1.13 Tuesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 0.45% to 27,599.79 and the Dow Jones Industrial Average rising 0.49% to 51,521.28.
This was the stock's fourth consecutive day of losses.
Inovio Pharmaceuticals Inc. closed 58.46% short of its 52-week high of $2.72, which the company achieved on December 17th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ rose 0.73% to $254.78, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ rose 0.33% to $27.50.
Trading volume (2.0 M) remained 2.5 million below its 50-day average volume of 4.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 6, 2026.